| |
New Diagnostic and Therapeutic Procedures
Indocyanine Green Angiography
by David Tom, M.D.
Spin-offs from NASA research and broadcasting camera technology
have enabled high spectral and spatial resolution charge-coupled
device (CCD) cameras to capture images in the visible and near infrared
wavelength regions. These cameras, together with high speed computer
processors and software image enhancement programs, enable us to
obtain valuable information, which not only helps physicians diagnose
but also treat more effectively the retinal diseases of our patients,
often in the same day.
Standard fluorescein angiography has proven to be helpful in demonstrating
and directing our laser treatments to well defined "classic"
neovascular lesions secondary to age-related macular degeneration
(ARMD). However, studies have shown that between 50 -85% of exudative
"wet" ARMD lesions are of the "occult" variety,
not amenable to laser treatment as per the Macular Photocoagulation
Study guidelines.
Enter Indocyanine Green (ICG) angiography. Although this dye was
in existence over a quarter century ago, it was not until high sensitivity
solid state cameras became available that ICG fundoscopic imaging
became a reality for the retina specialist. By imaging in the near-infrared
spectrum we are now able to observe retinal pathology (disease)
previously obscured by blood, lipid, and normal ocular pigment.
Furthermore, by virtue of being highly protein bound, the ICG dye
does not leak excessively from the choroidal vasculature as does
standard fluorescein dye, allowing excellent demonstration of the
vascular choroid, which lies between the retina and the sclera.
ICG technology, now available in our offices, has proven most useful
in the detection and laser ablation of so called "hot spots",
indicating areas of active neovascularization in ARMD. With standard
fluorescein angiography the standard protocol had been to treat
everything with laser, including areas of the retina that might
be uninvolved, because it was difficult to differentiate between
the two. The ICG technology now allows us to look at a deeper section
of the eye and see what is happening beneath the blood, so we can
spare those unaffected areas.

|
|